Ardent Health Partners (NYSE:ARDT) Stock Price Expected to Rise, Leerink Partners Analyst Says

Ardent Health Partners (NYSE:ARDT) had its target price upped by equities researchers at Leerink Partners from $23.00 to $25.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Leerink Partners’ price target points to a potential upside of 44.93% from the company’s current price.

Several other equities analysts have also issued reports on the company. KeyCorp started coverage on Ardent Health Partners in a report on Friday, October 11th. They set an “overweight” rating and a $24.00 price target on the stock. Morgan Stanley assumed coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They issued an “overweight” rating and a $27.00 price target for the company. Truist Financial initiated coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $21.00 price objective on the stock. Royal Bank of Canada assumed coverage on Ardent Health Partners in a research note on Monday, August 12th. They set an “outperform” rating and a $23.00 price target on the stock. Finally, Stephens reaffirmed an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $21.82.

Ardent Health Partners Price Performance

Shares of Ardent Health Partners stock opened at $17.25 on Tuesday. The business has a fifty day simple moving average of $18.42. Ardent Health Partners has a twelve month low of $14.57 and a twelve month high of $20.72. The company has a current ratio of 1.65, a quick ratio of 1.54 and a debt-to-equity ratio of 0.93.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.05. The firm had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. Analysts expect that Ardent Health Partners will post 1.28 EPS for the current year.

Institutional Investors Weigh In On Ardent Health Partners

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Seven Grand Managers LLC bought a new position in Ardent Health Partners during the third quarter valued at approximately $2,298,000. Allspring Global Investments Holdings LLC purchased a new position in Ardent Health Partners in the 3rd quarter worth $13,119,000. Finally, Financial Management Professionals Inc. bought a new stake in Ardent Health Partners in the third quarter worth $50,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.